Health
SK Bioscience starts developing vaccine against Covid-19 variants – Korea Biomedical Review
SK Bioscience said that it has set about to develop a vaccine to cope with Covid-19 variants with financial support from the Coalition for Epidemic Preparedness…
SK Bioscience said that it has set about to develop a vaccine to cope with Covid-19 variants with financial support from the Coalition for Epidemic Preparedness Innovations (CEPI), an international private organization.
The Korean company will receive up to $14.2 million (about 16 billion won) in research and development funds from CEPI to develop Covid-19 mutants using the development platform of GBP510, for which clinical trials are now underway.
SK Bioscience said it had also received additional…
-
General20 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Business24 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?
-
General18 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News23 hours agoBoat crash in Helensvale on the Gold Coast leaves man with life-threatening burns and another one injured